JOT Automation and Tensor ID Work on Syringe Inspection Platform
The companies will pre-promote their auto-injection syringe inspection platform at ATX West.
JOT Automation, a supplier of test and production solutions, and Tensor ID, specialists in machine vision solutions, will highlight the benefits of the companies' combined service and technology offering at ATX West as the companies exhibit together for the first time. The companies have started to codevelop a fully automated solution for the quality assurance of auto-injector syringes.
"Together we are pre-promoting an auto injection syringe inspection platform. The vision-based platform enables inspection of silicone coating inside glass syringes,” said Jorma Venäläinen, business line director of Life Sciences at JOT Automation, in the press release.
“The quality of silicone oil and its distribution on the inner syringe surface are two important factors that affect the injection performance of auto-injector devices. To better identify and screen out syringes with insufficient or non-uniform silicone oil distribution, our new technology visualizes, quantifies, and analyzes silicone oil distribution.”
"The market for auto-injectors is set to rise to 1.07 billion dollars by 2015," said Stacey Swall from Tensor ID in the press release. "In addition we see possibilities to exploit this technology for quality inspection of pipettes, vials and tubes.”
Source: JOT Automation
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
